A laboratory on Long Island has found a breakthrough in the fight against pancreatic cancer that can “intercept” its spread.

City of Hope researchers demonstrate proof of concept for a novel targeted therapy for pancreatic cancer, exploiting ...

Researchers have identified a new molecular target for treating pancreatic cancer. Scientists focused on transcription-replication conflicts (TRCs), which occur when the mechanisms responsible for ...

A new study focused on transcription-replication conflicts, which occur when mechanisms responsible for gene expression and ...

In a recent study, precancerous pancreatic lesions and some pancreatic ductal adenocarcinoma (PDAC) tumors harboring KRAS ...

Scientists have identified a key vulnerability in pancreatic cancer by targeting transcription-replication conflicts—cellular ...

Precancerous pancreatic lesions and some pancreatic ductal adenocarcinoma (PDAC) tumors harboring KRAS mutations had ...

Researchers at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S.

Results showed that FGFR2 gene deletion led to significantly fewer precancerous lesions and delayed PDAC tumor formation ...

Researchers at City of Hope have identified a new molecular target for treating pancreatic cancer, reports a Gastroenterology ...